Dexin announces strategic investment in Swedencare as pet food prospects grow
Symrise AG recently announced that it has agreed to make a strategic investment in Swedencare, a Swedish multinational supplier of pet health products.
Swedencare is in the process of raising additional capital, and Symrise's investment will be part of the additional capital. The investment has been unanimously approved by Swedencare and its management. Upon completion, DZX will hold a total of 5.06% of Swedencare's share capital.
Swedencare is a multinational company providing health products for cats, dogs and horses. Its product portfolio includes an all-natural oral care dietary supplement that is patented in more than 30 countries worldwide. There are also a variety of grooming products and other dietary supplements for joint and mobility enhancement.
We are looking forward to being a strategic shareholder in Swedencare to support this fast-growing business," said Heinz Jürgen Bertram, CEO of Dexin. Swedencare shares our passion for pet food solutions, which is impressive. With the trend of pet ownership growing rapidly in many markets, owners are choosing to provide their beloved pets with the best products to keep them healthy. swedencare's business is very profitable, has a diverse product offering and has international recognition."
2026-10-14
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Surging Demand for High-Protein Products in the Middle East Amidst Active Nutrition and Healthy Aging Boom
-
Exploring International Dietary Supplement Regulations: A Comprehensive Analysis of Dosage Forms and Approved Functional Ingredients in Key Markets
-
Global Pet Expo 2024: Everything You Need To Know
-
Nutrients + Functional Ingredients Lead The Way
-
FIC 2022 physical event will be held in Shanghai this March
-
in-cosmetics Asia 2021
-
Inventory of gluten-free food ingredients and functional ingredients added
-
Discovery and Application of Functional Cosmetic Ingredients
-
Sanofi’s $2.2 Billion Dynavax Acquisition: Why Big Pharma Is Rebuilding the Global Vaccine Order
-
AstraZeneca’s Wainua Fails Phase III Heart Trial, Wiping Out About $27 Billion in Market Value
Recommend Reading
-
Typhoon Bavi Hits Zhejiang and Fujian, Putting Two Major Petrochemical Hubs at Logistics Risk
-
Nippon Paint Offers $8.55 Billion for AkzoNobel’s Decorative Paints Business
-
China Eases July Fuel Export Curbs as Zhejiang Petrochemical Resumes Shipments
-
China’s Polyolefin Exports Keep Surging, Reversing the Global Plastics Trade Map
-
China Is Finally Moving on Petrochemical Plants, and This Time Low-Efficiency Capacity Really Is Being Forced Out
-
Business Society September 28, 2026 Lithium Carbonate Trend Analysis: Volatility
-
December Cyclohexane Market Operates Weakly, Lacking Momentum for Price Increases
-
On March 11, the pure benzene market in China continued to see a significant decrease
-
Business Society September 28, 2026 Styrene Trend Analysis: High-Level Volatility
-
Business Society: Both Supply and Demand Weak, Costs Hard to Sustain—Bisphenol A Set for Volatile Decline in 2025